Peer Review History: A Review on Targeted Drug Development for Breast Cancer Using Innovative Active Pharmaceutical Ingredients (APIs)

Editor(s):

(1) Prof. John Yahya I. Elshimali, Adjunct Professor, Charles R. Drew University of Medicine and Science, USA

(1) Prof. Ashish Anand. Associate Professor, William Carey School of Osteopathic Medicine, Mississipi, USA And University of Mississipi Medical Center, Mississipi, USA.

Reviewers:

(1) Muslim Bin Aqeel, University of Central Punjab, Pakistan.

(2) Makwana Rajeshreebahen Pravinkumar, Sardar Patel College of Pharmacy, India.

(3) Kavitha S, The Apollo University, India.

Additional Reviewers:

Additional Reviewers: (Comments received after deadline)

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage 8.33

Average Peer review marks at publication stage: 9/10

 

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer Review Report_1 (Muslim Bin Aqeel, Pakistan) | File 1 | NA


Stage 2 | Peer Review Report_2 (Makwana Rajeshreebahen Pravinkumar, India) | File 1 | NA


Stage 2 | Peer Review Report_3 (Kavitha S, India) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Posted in Review History.